PsiThera is a legitimate, high-potential biotechnology company specializing in AI-driven drug discovery for immunology (specifically the TNF superfamily). While the user submission contained significant inaccuracies (claiming '0' team members and 'everyone' as users), external verification confirms the company raised $47.5M in Series A funding (Dec 2025) and is a spin-out from Roivant Sciences. The project utilizes the QUAISAR platform, combining physics-based simulation with machine learning. The high score reflects the verified capital backing ($47.5M) and technical sophistication, despite the poor quality of the submission form.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline